IntrinsicIntrinsic
← All summaries

Qnity Electronics, Inc.

Q
Financials & Chart →

Business Summary

Qnity Electronics, Inc. is one of the largest global leaders in materials and solutions for the semiconductor and electronics industries, empowering customer technology roadmaps in megatrends such as artificial intelligence, high-performance computing and advanced connectivity. The company partners with leading semiconductor and advanced device manufacturers to address complex challenges and develop solutions for next-generation technological innovations, with over 50 years of experience in systems engineering and material science, a global manufacturing footprint and major application labs across the world. The semiconductor market has grown significantly over the last several decades, with trends including the proliferation of AI, high performance and cloud computing, 5G, next generation automotive vehicles and the IoT driving demand for semiconductors, while advancements in semiconductor technology lead to increased layering in chips requiring greater volume of manufacturing materials, more complex material formulations and higher price points. Geopolitical dynamics, including supply chain disruptions and government co-investment in semiconductor industries to ensure domestic supply, are creating new opportunities for semiconductor companies including Qnity.

The company's most notable competitors are Entegris, Merck KGA, Resonac, Element Solutions and MKS Instruments. Qnity believes its strengths include the breadth and depth of its product portfolio of critical solutions for innovation-driven, high-growth markets; deep customer intimacy with industry leaders, with the average length of its relationship with its top 10 customers exceeding 30 years; innovation leadership driven by superior materials science and engineering expertise; regionalized sourcing and production operations in key geographies, with approximately 70% of raw materials sourced local-for-local and approximately 80% of all products manufactured and sold within the same geographic region; a diversified and highly integrated supply chain with no supplier representing more than 10% of raw material spend; a well-invested, global manufacturing footprint with approximately 40 manufacturing sites and facilities across all geographic regions; operational excellence with over 50 years of experience; an attractive financial profile; and excellence in environmental, health and safety performance. The company is proud to count nearly all of the world's top 20 largest semiconductor manufacturers among its customers, and its top ten customers accounted for 34% of net sales in 2025.

Qnity generates revenue primarily through the sale of consumable or unit-driven products, with over 90% of Qnity's revenue in 2025 generated from products that are either utilized in the manufacturing process or incorporated into final electronic devices. The company's products are sold to supply manufacturers and distributors, with revenue recognized when the customer obtains control of the product, which occurs at a point in time, usually upon shipment, with payment terms typically in the range of 30 to 60 days after invoicing depending on business and geographic region. The company's diverse customer base includes semiconductor device manufacturers and foundries, equipment providers, circuit board manufacturers and other intermediaries within the electronics value chain, and it works as a design partner with OEMs, often working directly through their fabricator network. While the company has contracts with certain top customers, these contracts do not contain long-term purchase commitments; instead, the company works closely with customers to develop non-binding forecasts for the purchase and sale of products over the short-term.

The Semiconductor Technologies segment provides a portfolio of innovative materials and solutions utilized across multiple stages of the semiconductor manufacturing process, including advanced cleans and CMP slurries, CMP pads, lithographic materials, Kalrez specialized sealants, and advanced display materials. Key brands include PlasmaSolv, CuSolve, PCMPSolv, EtchSolv, Acuplane, Optiplane, Novaplane, IC1000, Ikonic, Visionpad, Optivision, Politex, Suba, Emblem, EPIC, EON, AR, MICROPOSIT, MEGAPOSIT, UVN, CTO, and SPR. For the year ended December 31, 2025, Semiconductor Technologies net sales were $2,642 million , up 8% from $2,450 million in the prior year, and Adjusted Operating EBITDA was $945 million , up 7% from $884 million in the prior year. The segment benefits from the "processing material multiplier" effect, as advanced nodes for logic and memory require three to five times more processing material per wafer compared to legacy nodes.

The Interconnect Solutions segment offers a comprehensive range of material solutions addressing the evolving complexities of signal integrity, thermal and power management and advanced packaging, with lines of business including Advanced Circuit & Packaging, Laird Technologies (thermal, EMI, power management), and Advanced Flex Technologies. Key brands include Circuposit, Ecoposit, Microfab, Microfill, Nikal, Riston, Skyton, Silveron, Solderon, Intervia, Tputty, Tflex, CoolZorb, Kapton, Oasis, Pyralux, and Interra. For the year ended December 31, 2025, Interconnect Solutions net sales were $2,112 million , up 12% from $1,885 million in the prior year, and Adjusted Operating EBITDA was $539 million , up 20% from $448 million in the prior year. The segment plays a vital role in the semiconductor value chain by enabling the seamless interconnection of various electronic components, encompassing advanced packaging, thermal and power management solutions and PCB materials.

On November 1, 2025, DuPont completed the Separation of Qnity through a pro-rata distribution of one share of Qnity common stock for every two shares of DuPont common stock held at the close of business on the record date of October 22, 2025, and Qnity common stock commenced trading on the New York Stock Exchange under the symbol "Q" at the start of trading on November 3, 2025. In connection with the Spin-Off, the company incurred indebtedness in an aggregate principal amount of $4.1 billion , consisting of the $2.35 billion Senior Secured Term Loan Facility, which was entered into on October 31, 2025, and the $1.0 billion of Senior Secured Notes due 2032 and $750 million of Senior Unsecured Notes due 2033, which were issued on August 15, 2025. The company also entered into the Senior Secured Revolving Facility of $1.25 billion on October 31, 2025. On December 2, 2025, the company and DuPont determined and agreed that the Applicable Qnity Percentage is 44% . The company currently estimates it will cost approximately $180 million in one-time costs, incurred over two years, to establish stand-alone information technology systems. On November 12, 2025 the Board of Directors declared a quarterly dividend of six cents ($0.06) per share, and on December 9, 2025 the Board of Directors declared a quarterly dividend of eight cents ($0.08) per share.

For the year ended December 31, 2025, total net sales were $4,754 million , up 10% from $4,335 million in 2024 and up from $4,035 million in 2023. Net income was $729 million in 2025, compared to $724 million in 2024 and $533 million in 2023. Net income available for Qnity common stockholders was $692 million in 2025, $693 million in 2024, and $507 million in 2023. Diluted earnings per share was $3.30 in 2025, $3.31 in 2024, and $2.42 in 2023. Cash provided by operating activities was $1,273 million in 2025, up from $1,061 million in 2024 and $882 million in 2023.

Business Outlook

The company's strategy centers on maintaining and strengthening its position in high growth, innovation-driven markets, recognizing that its products and solutions play a crucial role in the manufacturing of technologies related to artificial intelligence and data centers, high-performance computing, 5G networks, IoT, ADAS and EVs. The company aims to innovate further in next-generation technologies, leveraging its global footprint to facilitate local collaboration and co-development with industry-leading clients to address challenges related to performance, reliability and yield. The company also intends to grow through opportunistic acquisitions, building on its track record of successfully acquiring and integrating acquisitions with solutions that enhance and expand its portfolio.

The company's strategy includes leveraging operational excellence expertise, maintaining a competitive cost structure supported by ongoing productivity and efficiency improvements across its global manufacturing network, and continuing to invest in its supply chain and manufacturing capabilities to attain world-class process technologies that prioritize quality, automation, rapid design, prototyping and streamlined supply chain management. The company also aims to build on commercial excellence strengths as a customer-centric organization, with sales force effectiveness, disciplined product management, optimized route to market and key account management capabilities as critical elements of its commercial platform that help drive growth across both its existing customer base while continuing to scale into market adjacencies and new customer opportunities.

The company's financial objectives through 2028 include a disciplined capital allocation plan that focuses on driving organic growth, making strategic investments, pursuing opportunistic mergers and acquisitions, and returning capital to shareholders. The company's strategy includes driving systematic capital management and resource allocation, focusing on profitable growth and enhancing return on capital, leveraging its extensive global footprint to focus on targeted, modular and agile investments in its existing network rather than committing to new large-scale asset developments.

The company's research and development expenses totaled $354 million for the year ended December 31, 2025. The company expects to contribute approximately $6 million to its pension plans in 2026. As of December 31, 2025, the company is contractually obligated to make future cash payments of $4.1 billion and $1.7 billion associated with principal and interest, respectively, on debt obligations. Related to the principal, $24 million will be due in the next twelve months and the remainder will be due subsequent to 2026. Related to interest, $265 million will be due in the next twelve months and the remainder will be due subsequent to 2026.

The company faces structural headwinds from the cyclical nature of the semiconductor industry, which has historically experienced periodic downturns resulting in decreased demand for its products, and the company has previously experienced a reduction in revenue and operating losses during such downturns. The company also faces risks from trade disputes, regulations and policies, particularly those arising out of relations between the U.S. and China, as China represented approximately 33% of net sales for the year ended December 31, 2025. The company's international operations, which generated approximately 88% of total net sales for the year ended December 31, 2025, are subject to economic, geopolitical, foreign exchange and other risks, including trade restrictions and changes in tariffs.

The company faces execution risks related to its recent Spin-Off from DuPont, including the potential inability to achieve some or all of the expected benefits, substantial additional costs to operate as an independent company, and the incurrence of $4.1 billion in indebtedness in connection with the Spin-Off. The company also faces risks from its contractual allocation of certain liabilities, including the Applicable Qnity Percentage of 44% of certain legacy PFAS liabilities and other liabilities, and from restrictions under the Tax Matters Agreement that limit its strategic and operating flexibility for a period of two years following the Spin-Off.

Risk Factors

The company's revenue is heavily dependent on demand from the global semiconductor ecosystem, which has historically been cyclical with periodic downturns, and the company has previously experienced a reduction in revenue and operating losses during such downturns. The company's international operations generated approximately 88% of total net sales for the year ended December 31, 2025, with Asia Pacific representing approximately 79% , exposing the company to economic, geopolitical, foreign exchange and other risks, including trade restrictions and changes in tariffs, particularly with China which represented approximately 33% of net sales. The company incurred $4.1 billion in indebtedness in connection with the Spin-Off, which could require a substantial portion of cash flow from operations to make interest payments and increase vulnerability to adverse economic conditions. The company is contractually allocated the Applicable Qnity Percentage of 44% of certain legacy PFAS liabilities and other liabilities, including funding obligations under the MOU, and as of December 31, 2025 has recorded indemnification liabilities of $80 million within current liabilities and $110 million within noncurrent obligations for these legacy liabilities, with potential exposure that could range up to $86 million above the amount accrued.

Management Priorities

Management's message emphasizes that Qnity is one of the largest global leaders in materials and solutions for the semiconductor and electronics industries, empowering customer technology roadmaps to enable advancements in megatrends such as artificial intelligence, high-performance computing and advanced connectivity. The company's strategy centers on several key factors including maintaining and strengthening its position in high growth, innovation-driven markets; innovating further in next-generation technologies; leveraging operational excellence expertise; building on commercial excellence strengths; driving systematic capital management and resource allocation; recruiting and developing talent; responding to customers' demand for sustainable products; and growing through opportunistic acquisitions. The company's financial objectives through 2028 include a disciplined capital allocation plan that focuses on driving organic growth, making strategic investments, pursuing opportunistic mergers and acquisitions, and returning capital to shareholders.

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 7, MD&A — Segment Results, Semiconductor Technologies
  2. [2] Item 7, MD&A — Segment Results, Semiconductor Technologies
  3. [3] Item 7, MD&A — Segment Results, Semiconductor Technologies
  4. [4] Item 7, MD&A — Segment Results, Semiconductor Technologies
  5. [5] Item 7, MD&A — Segment Results, Interconnect Solutions
  6. [6] Item 7, MD&A — Segment Results, Interconnect Solutions
  7. [7] Item 7, MD&A — Segment Results, Interconnect Solutions
  8. [8] Item 7, MD&A — Segment Results, Interconnect Solutions
  9. [9] Item 1A, Risk Factors — Risks Related to our Recent Spin-Off from DuPont
  10. [10] Item 7, MD&A — Liquidity & Capital Resources, Long-Term Debt
  11. [11] Item 7, MD&A — Liquidity & Capital Resources, Long-Term Debt
  12. [12] Item 7, MD&A — Liquidity & Capital Resources, Long-Term Debt
  13. [13] Item 7, MD&A — Liquidity & Capital Resources, Overview
  14. [14] Item 7, MD&A — Transition to Stand-Alone Company, Certain Indemnification Obligations to DuPont
  15. [15] Item 7, MD&A — Transition to Stand-Alone Company, Stand-Alone Company Expenses
  16. [16] Item 7, MD&A — Liquidity & Capital Resources, Dividends
  17. [17] Item 7, MD&A — Liquidity & Capital Resources, Dividends
  18. [18] Item 7, MD&A — Results of Operations, Summary of Sales Results
  19. [19] Item 7, MD&A — Results of Operations, Summary of Sales Results
  20. [20] Item 7, MD&A — Results of Operations, Summary of Sales Results
  21. [21] Item 8, Consolidated Statements of Operations
  22. [22] Item 8, Consolidated Statements of Operations
  23. [23] Item 8, Consolidated Statements of Operations
  24. [24] Item 8, Consolidated Statements of Operations
  25. [25] Item 8, Consolidated Statements of Operations
  26. [26] Item 8, Consolidated Statements of Operations
  27. [27] Item 8, Consolidated Statements of Operations
  28. [28] Item 8, Consolidated Statements of Operations
  29. [29] Item 8, Consolidated Statements of Operations
  30. [30] Item 8, Consolidated Statements of Cash Flows
  31. [31] Item 8, Consolidated Statements of Cash Flows
  32. [32] Item 8, Consolidated Statements of Cash Flows
  33. [33] Item 7, MD&A — Results of Operations, Research and Development Expense
  34. [34] Item 7, MD&A — Liquidity & Capital Resources, Pension and Other Post-Employment Plans
  35. [35] Item 7, MD&A — Liquidity & Capital Resources, Material Cash Requirements
  36. [36] Item 7, MD&A — Liquidity & Capital Resources, Material Cash Requirements
  37. [37] Item 7, MD&A — Liquidity & Capital Resources, Material Cash Requirements
  38. [38] Item 7, MD&A — Liquidity & Capital Resources, Material Cash Requirements
  39. [39] Item 1A, Risk Factors — Risks related to trade disputes, regulations and policies
  40. [40] Item 1A, Risk Factors — A large percentage of our net sales are generated from our international operations
  41. [41] Item 1A, Risk Factors — Risks Related to our Recent Spin-Off from DuPont
  42. [42] Item 7, MD&A — Transition to Stand-Alone Company, Certain Indemnification Obligations to DuPont
  43. [43] Item 1A, Risk Factors — A large percentage of our net sales are generated from our international operations
  44. [44] Item 1A, Risk Factors — A large percentage of our net sales are generated from our international operations
  45. [45] Item 1A, Risk Factors — Risks related to trade disputes, regulations and policies
  46. [46] Item 1A, Risk Factors — Risks Related to our Recent Spin-Off from DuPont
  47. [47] Item 7, MD&A — Transition to Stand-Alone Company, Certain Indemnification Obligations to DuPont
  48. [48] Item 8, Note 15 — Commitments and Contingent Liabilities, Certain Indemnification Obligations to DuPont
  49. [49] Item 8, Note 15 — Commitments and Contingent Liabilities, Certain Indemnification Obligations to DuPont
  50. [50] Item 8, Note 15 — Commitments and Contingent Liabilities, Certain Indemnification Obligations to DuPont
  51. [51] Item 8, Consolidated Statements of Operations
  52. [52] Item 8, Consolidated Statements of Operations
  53. [53] Item 8, Consolidated Statements of Operations
  54. [54] Item 8, Consolidated Statements of Operations
  55. [55] Item 8, Consolidated Statements of Operations
  56. [56] Item 8, Consolidated Statements of Operations
  57. [57] Item 8, Consolidated Statements of Operations
  58. [58] Item 8, Consolidated Statements of Operations
  59. [59] Item 8, Consolidated Statements of Operations
  60. [60] Item 8, Consolidated Statements of Operations
  61. [61] Item 8, Consolidated Statements of Operations
  62. [62] Item 8, Consolidated Statements of Operations
  63. [63] Item 8, Consolidated Statements of Operations
  64. [64] Item 8, Consolidated Statements of Operations
  65. [65] Item 8, Consolidated Statements of Operations
  66. [66] Item 7, MD&A — Results of Operations, Provision for Income Taxes
  67. [67] Item 7, MD&A — Results of Operations, Provision for Income Taxes
  68. [68] Item 7, MD&A — Results of Operations, Provision for Income Taxes
  69. [69] Item 8, Consolidated Balance Sheets
  70. [70] Item 8, Consolidated Balance Sheets
  71. [71] Item 7, MD&A — Liquidity & Capital Resources, Overview
  72. [72] Item 8, Consolidated Statements of Cash Flows
  73. [73] Item 8, Consolidated Statements of Cash Flows
  74. [74] Item 8, Consolidated Statements of Cash Flows
  75. [75] Item 8, Consolidated Statements of Cash Flows
  76. [76] Item 8, Consolidated Statements of Cash Flows
  77. [77] Item 8, Consolidated Statements of Cash Flows
  78. [78] Item 7, MD&A — Results of Operations, Research and Development Expense
  79. [79] Item 7, MD&A — Results of Operations, Research and Development Expense
  80. [80] Item 7, MD&A — Results of Operations, Research and Development Expense
  81. [81] Item 7, MD&A — Results of Operations, Amortization of Intangibles
  82. [82] Item 7, MD&A — Results of Operations, Amortization of Intangibles
  83. [83] Item 7, MD&A — Results of Operations, Amortization of Intangibles
  84. [84] Item 7, MD&A — Results of Operations, Restructuring and Asset Related Charges - Net
  85. [85] Item 7, MD&A — Results of Operations, Restructuring and Asset Related Charges - Net
  86. [86] Item 7, MD&A — Results of Operations, Restructuring and Asset Related Charges - Net
  87. [87] Item 7, MD&A — Results of Operations, Acquisition, Integration and Separation Costs
  88. [88] Item 7, MD&A — Results of Operations, Interest Expense
  89. [89] Item 7, MD&A — Segment Results, Semiconductor Technologies
  90. [90] Item 7, MD&A — Segment Results, Semiconductor Technologies
  91. [91] Item 7, MD&A — Segment Results, Interconnect Solutions
  92. [92] Item 7, MD&A — Segment Results, Interconnect Solutions

Analysis on 6/19/2026